GLP-1 Coverage & Costs in Indiana (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Indiana at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Indiana Medicaid Coverage for GLP-1
Medicaid: not covered as of January 2026 (KFF)
KFF's map lists Indiana as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Your Options in Indiana:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Indiana
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
Indiana Medicaid GLP-1 Prescriptions in 2025
190,013
#15
$203.2 million
Ozempic
Indiana Medicaid paid for 190,013 GLP-1 prescriptions in 2025, 1.7% of the 11.26 million paid nationally and number 15 of 51 (50 states and DC). It reimbursed pharmacies $203.2 million before manufacturer rebates, about $1,070 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 8,749 of those prescriptions (4.6%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Indiana Medicaid GLP-1 prescriptions went from 100,728 to 190,013, 1.9 times the 2021 count. From 2024 to 2025 the count fell by 8,656.
100,728
143,176
201,387
198,669
190,013
| Product | IN Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Ozempic | 135,539 | 71.3% |
| Trulicity | 29,049 | 15.3% |
| Mounjaro | 13,709 | 7.2% |
| Zepbound | 5,452 | 2.9% |
| Wegovy | 3,297 | 1.7% |
| Liraglutide (generic) | 1,307 | 0.7% |
| Rybelsus | 980 | 0.5% |
| Victoza | 550 | 0.3% |
| Bydureon | 79 | under 0.1% |
| Byetta | 51 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Indiana Employee Plan and Insurer GLP-1 Rules
State of Indiana employee health plan
Does not cover GLP-1s for weight lossIndiana's state employee pharmacy benefit stopped covering GLP-1 drugs used for weight loss on January 1, 2026.
The State Personnel Department says weight-loss GLP-1s left the state's pharmacy benefit on January 1, 2026.
“Effective January 1, 2026, GLP-1 drugs used for weight loss will no longer be covered under the State’s pharmacy benefit.”
Source: Indiana State Personnel Department. Read October 29, 2026.
We have no Indianainsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.
Comparing self-pay programs in Indiana?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Indiana
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Indiana. The rest record a state count without naming the states, so confirm Indiana with the program at intake before you pay.
What Programs' Own Pages Say About Indiana
8 of the 8 programs whose own pages name the states they serve include Indiana: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Indiana |
|---|---|
| Willow | Serves IN |
| SnagRx | Serves IN |
| Strut Health | Ships to IN |
| MangoRx | Ships to IN |
| Wellorithm | Serves IN |
| MEDGm | Serves IN |
| TelosRx | Serves IN |
| Trimi | Serves IN |
Trimi's state table lists Indiana as served through the Arora Health network. Visit format there: Online evaluation through the Arora Health network. The telehealth law it cites for Indiana is Ind. Code § 25-1-9.5-8 (with §§ 25-1-9.5-6 and 25-1-9.5-7). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Indiana
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Indiana, 2024
Indiana prescribers wrote 559,402 Medicare Part D GLP-1 claims in 2024, number 12 of 51, with $734.6 million in gross drug cost before rebates. Ozempic led with 259,233 claims for 51,227 enrollees. Wegovy had 4,619 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | IN Part D claims | Enrollees |
|---|---|---|
| Ozempic | 259,233 | 51,227 |
| Mounjaro | 162,641 | 28,608 |
| Trulicity | 94,899 | 18,875 |
| Rybelsus | 25,682 | 6,533 |
| Victoza | 6,385 | Not given |
| Bydureon Bcise | 4,688 | 1,035 |
| Wegovy | 4,619 | 1,284 |
| Liraglutide | 945 | 388 |
| Byetta | 296 | 74 |
| Zepbound | 14 | 12 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Indiana
The Bridge is national, so the rules are the same in Indiana as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Indiana Compares to Other Midwest States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Indiana and its neighbors in the Midwest are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Indiana (this page) | Not covered | 190,013 |
| Illinois | Not covered | 288,470 |
| Iowa | Not covered | 88,518 |
| Kansas | Covered, January 2026 (KFF) | 50,850 |
| Michigan | Covered, January 2026 (KFF) | 607,982 |
| Minnesota | Covered, January 2026 (KFF) | 230,594 |
| Missouri | Covered, January 2026 (KFF) | 285,105 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for Indiana Cities
If Your Insurance Denies GLP-1 Coverage in Indiana
Commercial plans offer an internal appeal, then external review; Indiana Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Indiana
- Indiana Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: State of Indiana employee health plan, does not cover glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Indiana
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Indiana.
Frequently Asked Questions — Indiana
Does Indiana Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Indiana Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Indiana in 2024?
Does the Indiana state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Indiana?
Which online GLP-1 programs serve Indiana?
Does Medicare cover GLP-1s in Indiana?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.